MRMartina Rella

Martina Rella

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Martina Rella has a total of 23 co-authors. Here are the top co-authors by number of shared publications:

  • Angelo Cignarelli

    Department of Precision and Regenerative Medicine and Ionian Area-Section of Internal Medicine, Endocrinology, Andrology and Metabolic Diseases, University of Bari Aldo Moro, 70121 Bari, Italy

    1 shared publication
  • Anna Borrelli

    Department of Precision and Regenerative Medicine and Ionian Area, Section of Internal Medicine, Endocrinology, Andrology and Metabolic Diseases, University of Bari Aldo Moro, Bari, Italy

    1 shared publication
  • Anna Signorile

    Department of Translational Biomedicine and Neuroscience, University of Bari Aldo Moro, Bari, Italy

    1 shared publication
  • Annalisa Natalicchio

    Department of Precision and Regenerative Medicine and Ionian Area, Section of Internal Medicine, Endocrinology, Andrology and Metabolic Diseases University of Bari Aldo Moro Bari Italy

    1 shared publication
  • Antonio Moretti

    Institute of Sciences of Food Production, National Research Council of Italy, (CNR-ISPA), Bari, Italy

    1 shared publication
  • Cristina Caccioppoli

    Department of Precision and Regenerative Medicine and Ionian Area, Section of Internal Medicine, Endocrinology, Andrology and Metabolic Diseases, University of Bari Aldo Moro, Bari, Italy

    1 shared publication

Latest Publications

  • Open Access

    The myokine irisin ameliorates the secretory dysfunction of pancreatic β cells in experimental and human type 2 diabetes

    by Nicola Marrano, Anna Borrelli, Giuseppina Biondi, Martina Rella, Rossella D’ORia, Valentina Annamaria Genchi, Cristina Caccioppoli, Valerio Galasso, Giovanni Galluzzi, Luca Roberto, et al.

    Irisin is a myokine that enhances insulin secretion and β cell viability in both rodent and human β cells. Here, we investigated whether irisin preserves β cell functional mass in vivo in diabetic mice and ex vivo in human pancreatic islets from subjects with type 2 diabetes (T2D). In mice made diabetic by a high-fat diet and streptozotocin, irisin administration improved glycemic homeostasis by increasing islet insulin content and glucose-stimulated insulin secretion while also markedly stimulating β cell proliferation. In islets from T2D subjects, which typically display substantial structural and functional impairments, irisin restored insulin content and glucose-stimulated insulin secretion. Mechanistic studies in INS-1E cells showed that chronic exposure to high glucose blunted glucose-triggered cytoplasmic calcium increases, essential for insulin secretion. Under these glucotoxic conditions, while irisin was unable to activate CREB and AKT, it induced AMPK-mTORC1-S6K–dependent mobilization of endoplasmic reticulum calcium stores, resulting in enhancement of insulin secretion. Overall, these findings highlight irisin’s multifaceted ability to counteract β cell failure in experimental and human T2D.